
Sign up to save your podcasts
Or


Derek Maetzold, CEO of Castle Biosciences shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Castle is leveraging its expertise in cancer genomics and the use of artificial intelligence to improve patient outcomes.
By John Simboli5
77 ratings
Derek Maetzold, CEO of Castle Biosciences shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Castle is leveraging its expertise in cancer genomics and the use of artificial intelligence to improve patient outcomes.

534 Listeners

3,072 Listeners

1,091 Listeners

940 Listeners

795 Listeners

125 Listeners

322 Listeners

96 Listeners

9,942 Listeners

34 Listeners

519 Listeners

146 Listeners

349 Listeners

182 Listeners

467 Listeners